Results 11 to 20 of about 661 (153)

Racecadotril Versus Loperamide for Acute Diarrhea of Infectious Origin in Adults: A Systematic Review and Meta‐Analysis

open access: yesHealth Science Reports
Background and Aims Loperamide and racecadotril are two antidiarrheal medications with different mechanisms of action that are highly important for the treatment of diarrhea as a result of infectious pathology.
Maryam Aziz   +12 more
doaj   +2 more sources

Racecadotril versus loperamide for the treatment of acute diarrhoea

open access: yesThe Egyptian Journal of Internal Medicine, 2023
Poulami Roy, Novonil Deb
doaj   +2 more sources

Design, synthesis, and evaluation of novel racecadotril-tetrazole-amino acid derivatives as new potent analgesic agents

open access: yesResearch in Pharmaceutical Sciences, 2021
Background and purpose: Although pain is one of the most common symptoms of diseases, it is often mismanaged due to limited access to painkillers and ineffectiveness, unacceptable side effects, or the possibility of abuse.
Mehdi Asadi   +5 more
doaj   +1 more source

Hospital Based Prospective Observational Study to Audit the Prescription Practices and Outcomes of Paediatric Patients (6 months to 5 years age group) Presenting with Acute Diarrhea [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Introduction: Diarrhea is a leading killer of children, accounting for 9% of all deaths among under-five children worldwide. WHO protocol deviation in management of diarrheas in children is likely due to various reasons.
Tapobrata De   +2 more
doaj   +1 more source

ACUTE GASTROENTERITIS IN CHILDREN-THERAPEUTIC PRINCIPLES [PDF]

open access: yesRomanian Journal of Pediatrics, 2008
This report presents updated recommendations for the optimal management of acute gastroenteritis in childhood, according to fundamental therapeutical principles recommended by ESPGHAN ( European Society of Paediatric Gastroenterology, Hepatology and ...
Victoria Hurduc   +4 more
doaj   +1 more source

Randomized trial to assess the efficacy and safety of xyloglucan for the treatment of acute gastroenteritis in children

open access: yesFood Science &Nutrition, Volume 11, Issue 12, Page 7698-7706, December 2023., 2023
Xyloglucan is effective and safe in moderate‐to‐severe diarrhea in children 3 months to 5 years. Abstract Acute gastroenteritis is one of the most common diseases in children and an important cause of morbidity and mortality worldwide. No specific treatment is available; therefore, management is exclusively symptomatic.
Maria Jose Perez‐Garcia   +17 more
wiley   +1 more source

Gelatin tannate for acute childhood gastroenteritis: a randomized, single-blind controlled trial [PDF]

open access: yes, 2016
Background Oral rehydration therapy is the recommended treatment for acute childhood gastroenteritis. The aim of this study was to assess the efficacy and safety of gelatin tannate plus oral rehydration compared with oral rehydration alone.
Aloi, Marina   +5 more
core   +1 more source

Concomitant medication in patients with bradykinin‐mediated angioedema – there's more than ACE inhibitors

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 21, Issue 11, Page 1283-1289, November 2023., 2023
Summary Bradykinin‐mediated angioedema is a rare, non‐allergic, potentially life‐threatening disease. ACE inhibitor‐induced angioedema and hereditary angioedema (HAE) are the two most common presentations. Therapeutic options, pathophysiology and diagnosis continue to be investigated, with considerable progress in HAE over the last few decades. For all
Robin Lochbaum   +3 more
wiley   +1 more source

Racecadotril for acute diarrhoea in children: systematic review and meta-analyses [PDF]

open access: yes, 2015
OBJECTIVE Racecadotril is an antisecretory agent that can prevent fluid/electrolyte depletion from the bowel as a result of acute diarrhoea, without affecting intestinal motility. An up-to-date systematic review is indicated to summarise the evidence on
Alam   +31 more
core   +1 more source

Medikamente als Auslöser Bradykinin‐vermittelter Angioödeme – mehr als ACE‐Hemmer

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 21, Issue 11, Page 1283-1290, November 2023., 2023
Zusammenfassung Bradykinin‐vermittelte Angioödeme sind seltene, nichtallergische und potenziell lebensbedrohliche Krankheiten. Die beiden bekanntesten Formen sind das ACE‐Hemmer‐induzierte Angioödem und das hereditäre Angioödem (HAE). Die therapeutischen Möglichkeiten, die Pathophysiologie und die Diagnostik werden weiter erforscht, wobei beim HAE in ...
Robin Lochbaum   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy